Kevin Mannix

Corporate Officer/Principal chez

Apotex Corp.

Health Technology

Consumer Services

Profil

Kevin C.
Mannix is Vice President & Global Head-Capital Markets at Apotex Corp.
since 2024.
Formerly, Mr. Mannix was Head-Investor Relations at Teva North America, Senior Vice President-Investor Relations at BeOne Medicines Ltd., and Senior Vice President-Investor Relations at Teva Pharmaceutical Industries Ltd. from 2003 to 2021.
Mr. Mannix completed undergraduate education at Siena College in 1993.

Postes actifs de Kevin Mannix

Sociétés	Poste	Début
Apotex Corp. Apotex Corp. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products	Corporate Officer/Principal	01/10/2024

Tous les postes actifs de Kevin Mannix

Anciens postes connus de Kevin Mannix

Sociétés	Poste	Fin
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Investor Relations Contact	01/12/2021
BEIGENE LTD	Investor Relations Contact	-
Teva North America	Investor Relations Contact	-

Voir l'expérience en détail de Kevin Mannix

Formation de Kevin Mannix

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kevin Mannix

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients	Health Technology
Siena College Siena College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Teva North America
Apotex Corp. Apotex Corp. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products	Health Technology
BeiGene Ltd. BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology